Abstract
Following successful adherence and colonization of host tissues by invading mycoplasmas, interactions between organisms and their host immune system are initiated. Specific, protective antimycoplasmal humoral and cellular immune responses are often only partially effective, thus leading to a chronic persistent infection. In addition, mycoplasmas can induce nonspecific modulation of host immune responses thereby contributing to the immuno-pathological manifestations of mycoplasmal infections. Nonspecific suppression of host immune responses may affect the host’s capacity to eradicate the evading mycoplasma and it also may render the host more susceptible to infections with other microorganisms. On the other hand, nonspecific-mitogenic activation of host immune mechanisms may be responsible for the massive cellular responses, lymphoid hyperplasia, cell infiltration, inflammation and chemotactic phenomena which often characterize mycoplasma infections. It is obvious that the immune mechanisms operating during any mycoplasma infection are complex and depend on both the mycoplasma species and the infected host. It is therefore crucial to clarify in each case the nature of specific as well as nonspecific interactions between the invading mycoplasma and its host immune cells. This paper will address the capacity of mycoplasmas to modulate immune responses either by suppression or by nonspecific activation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldrige, K. E., Cole, B. C. and Ward, J. R. (1977a) Mycoplasma dependent activation of normal lymphocytes: Induction of a lymphocyte mediated cytotoxicity for allogeneic and syngeneic mouse target cells. Infect. Immun. 18:377–385.
Aldrige, K. E., Cole, B. C. and Ward, J. R (1977b) Mycoplasma dependent activation of normal lymphocytes: Role of arginine and non-viable mycoplasma antigen in the induction of lymphocyte mediated cytotoxicity for syngeneic mouse target cells Infect Immun 18:386–392.
Al-Samarrai, T. H., Smith, P. F. and Lynn, R. J. (1982) Isolation and characterization of the receptor on sheep erythrocytes for acholeplasmal lipoglycans Infect. Immun. 38:1078–1087.
Atkin, C. L., Cole, B. C., Sullivan, G. J, Washburn L. R. and Wiley, B. B. (1986) Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis V. A small basic protein from culture supernatants is a potent T-cell mitogen. J. Immunol. 137:1581–1589.
Barile, M. F. and Leventhal, B. G. (1968) Possible mechanism for mycoplasma inhibition of lymphocyte transformation induced by phytohaemagglutinin. Nature, (London) 219:751.
Biberfeld, G. (1977) Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae. Scand. J. Immunol. 6:1145–1150.
Biberfeld, G., Biberfeld, P. and Sterner, G. (1974) Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation. Clin. Exp. Immunol 17:29–41.
Biberfeld, G. and Gronowicz, E. (1976) Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature 261:238–239.
Biberfeld, G. and Nilsson, E. (1978) Mitogenicity of Mycoplasma fermentans for human lymphocytes. Infect. Immun. 21:48–54.
Biberfeld, G., Arneborn, P., Forsgren, M., Von Stedingk, L. V. and Blomqvist, S. (1983) Non-specific polyclonal antibody response induced by Mycoplasma pneumoniae in vitro and in vivo. Yale J. Biol. & Med. 56:639–642.
Brunner, H., Kahling, U., Rollberg, A., Beck, J. and Kirchner, H (1983) Effect of Mycoplasma pneumoniae and some of its fractions on host defense mechanisms. Yale J. Biol. & Med. 56:63–864.
Cassell, G. H. and Hill, A. (1979) Murine and other small animal mycoplasmas, in “The Mycoplasmas” Vol IL (Tully, J. G. and Whitcomb, R. F., Eds.), pp. 235–273, Academic Press, New York.
Cole, B. C., Golightly-Rowland, L. and Ward, J. R. (1975) Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice. Infect. Immun. 12:1083–1092.
Cole, B. C., Aldridge, K. E. and Ward, J. R. (1977) Mycoplasma-dependent activation of normal lymphocytes: Mitogenic potential of mycoplasmas for mouse lymphocytes. Infect. Immun. 18:393–399.
Cole, B. C., Aldridge, K. E., Sullivan, G. J. and Ward, J. R. (1980) Mycoplasma dependent activation of normal mouse lymphocytes: requirement for functional T-lymphocytes in the cytotoxicity reaction mediated by Mycoplasma arthritidis. Infect. Immun. 30:90–98.
Cole, B. C., Daynes, R. A. and Ward, J. R. (1981) Stimulation of lymphocytes by a mitogen derived from Mycoplasma arthritidis. I. Transformation is associated with an H-2 linked gene that maps to the I-E/I-C subregion. J. Immunol. 127:1931–1936.
Cole, B. C., Sullivan, G. J., Daynes, R. A., Sayed, I. A. and Ward, J. R. (1982) Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. II. Cellular requirements for T-cell transformation mediated by a soluble mycoplasma mitogen. J. Immunol. 128:2013–2018.
Cole, B. C., Naot, Y., Stanbridge, E. S. and Wise, K. S. (1985) Interactions of mycoplasmas and their products with lympoid cells in vitro, in “The Mycoplasmas” Vol. IV, (Razin, S. Barile, M. F., Eds.), pp. 203–257, Academic Press, New York.
Cole, B. C., Tuller, J. W. and Sullivan, G. J. (1987) Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the Eα bearing RIIIS mouse strain that is associated with a specific lack of T-cell responses to the M. arthritidis soluble mitogen. J. Immunol. 139:927–935.
Cole, B. C., Kartchner, D. R. and Wells, D. J. (1989) Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VII. Responsiveness is associated with expression of a product(s) of the gene family present on the T-cell receptor α/β for antigen J. Immunol. 142:4131–4137.
Cole, B. C., Kartchner, D. R. and Wells, D. J. (1990) Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T-cells expressing distinct Vβ T-cell receptors from various strains of mice by the “Superantigen” MAM. J. Immunol. 144:425–431.
Cole, B. C. and Wells, D. J. (1990) Immunosuppressive properties of the Mycoplasma arthritidis T-cell mitogen in vivo: inhibition of proliferative responses to T-cell mitogens. Infect. Immun. 58:228–236.
Copperman, R. and Morton, H. E. (1966) Reversible inhibition of mitosis in lymphocyte cultures by nonviable mycoplasma. Proc. Soc. Exp. Biol. Med. 123:790–795.
Davis, J. K., Thorp, R. B., Maddox, P. A. and Brown, M. B. (1982) Murine respiratory mycoplasmosis in F 344 and LEW rats: evolution of lesions and lung lymphoid cell populations. Infect. Immun. 36:720–729.
Davis, J. K., Simecka, J. W., Williamson, J. S. P., Ross, S. E., Juliana, M. M, Thorp, R. B. and Cassell, G. H. (1985) Non-specific lymphocyte responses in F 344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences. Infect. Immun. 49:152–158.
Gabridge, M. G. and Schneider, P. R. (1975) Cytotoxic effect of Mycoplasma fermentans on mouse thymocytes. Infect. Immun. 11:460–465.
Giebler, D., Brehm, G., Nicklas, W. and Kirchner, H. (1986) Activation of C57BL/6 spleen cells by the mitogenic principle derived from Mycoplasma arthritidis. Immunol. 171:57
Ginsburg, H. and Nicolet, J. (1973) Extensive transformation of lymphocytes by a mycoplasma organism. Nature, (New Biol.) 246:143–146.
Ginsburg, H., Naot, Y. and Hollander, N. (1976) Lysis and necrosis: analysis of two cytotoxic phenomena mediated by lymphocytes. Israel J. Med. Sci. 12:435–453.
Kaklamanis, E. and Pavlatos, M. (1972) The immunosuppressive effect of mycoplasma infection. I. Effect on the humoral and cellular response. Immunology, 22:695–702.
Katz, R., Siman-Tov, R. and Naot, Y. (1983) Comparison of mitogens from Mycoplasma pulmonis and Mycoplasma neurolyticum. Yale J. Biol, and Med. 56:613–621
Keystone, E. C., Cunningham, A. J., Metcalf, A., Kennedy, M. and Quinn, P. A. (1982) Role of antibody in the protection of mice from arthritis induced by Mycoplasma pulmonis. Clin. Exp. Immunol. 47:253–259.
Kirchner, H., Brunner, H. and Ruhl, H. (1977) Effect of A. laidlawii on murine and human lymphocyte cultures. Clin. Exp. Immunol. 29:176–180.
Kirchner, H., Giebler, D., Keyssner, K. and Nicklas, W. (1984) Lymphoproliferation induced in mouse spleen cells by Mycoplasma arthritidis mitogen reversal of the defect of nonresponder mice. Scand. J. Immunol. 20:133–139.
Lapidot, Z. and Naot, Y. (1990) Monoclonal antibodies inhibiting Mycoplasma pulmonis IOM Letts. 1:133.
Levin; D., Gershon, H. and Naot, Y. (1985) Production of Interleukin-2 by rat lymph node cells stimulated by Mycoplasma pulmonis membranes. J. Infect. Dis. 151:541–544.
Lynn, R. J. (1982) Modulation of the immune response with acholeplasmal lipoglycans. Rev. Infect. Dis. 4 suppl, S270
Moritz, T., Giebler, D., Gunther, E., Nicklas, W. and Kirchner, H. (1984) Lymphoproliferative responses of spleen cells of inbred rat strains to Mycoplasma arthritidis mitogen. Scand. J. Immunol. 20:991–996.
Naot, Y., Tully, J. G. and Ginsburg, H. (1977) Lymphocyte activation by various Mycoplasma strains and species. Infect. Immun. 18:310–317.
Naot, Y. and Ginsburg, H. (1978) Activation of mouse B-lymphocytes by mycoplasma mitogen(s). Immunology, 34:715–720
Naot, Y., Siman-Tov, R. and Ginsburg, H. (1979a) Mitogenic activity of Mycoplasma pulmonis. II. Studies on the biochemical nature of the mitogenic factor. Eur. J. Immunol. 9:149–154.
Naot, Y., Merchav, S., Ben-David, E. and Ginsburg, H. (1979b) Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B-and T-lymphocytes. Immunol. 36:399–406.
Naot, Y., Davidson, S. and Lindenbaum, E. S. (1981) Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic mycoplasmal membranes. J. Infect. Dis. 143:55–62.
Simecka, J. W., Davis, J. K. and Cassell, G. H. (1989) Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F 344 rats. Infect. Immun. 57:3570–3575.
Smith, P. F. (1984) Lipoglycans from mycoplasmas. Critical Rev. Microbiol. 11:157–186.
Sugiyama, T., Smith, P. F., Langworthy, T. A. and Mayberry, W. R. (1974) Immunological analysis of glycolipids and lipopolysaccharides derived from various mycoplasmas. Infect. Immun. 10:1273–1279.
Tumang, J. R., Posnett, D. N., Cole, B. C., Crow, M. K. and Friedman, S. M. (1990) Helper T-cell dependent human B-cell differentiation mediated by a mycoplasmal superantigen bridge. J. Exp. Med. 171:2153–2158.
Williamson, J. S. P., Davis, J. K. and Cassell, G. H. (1986) Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response. Infect. Immun. 52:594–599.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Naot, Y. (1993). Mycoplasmas as Immunomodulators. In: Rapid Diagnosis of Mycoplasmas. Federation of European Microbilogical Societies Symposium Series, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2478-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2478-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6056-8
Online ISBN: 978-1-4615-2478-6
eBook Packages: Springer Book Archive